u/week_four_wall

The confident tone is doing a lot of work that the evidence is not.

no advice on evading inspection or misdeclaring

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the Denmark versus Denmark distinction is real

the Poland versus Poland distinction is real

seizure letters: redact everything identifying

co-elution is real and chromatogram is usually not enough to resolve it

Disagree on that part. 97.9% and 97.6% on the same vial is normal.

Crossposting this to c/vendorvetting because the people who need it are not reading this community.

Adding to this: HPLC is doing more work than the comment implies.

the Denmark import rules are specific to Denmark

Strongly agree. Jurisdiction matters.

no naming compounders operating against current rules

Dead space in the needle hub holds a small but non-trivial volume.

Adding to this: LC-MS is doing more work than the comment implies.

declared value is seizure, impacts duty

the 24mg import allowance is Spain-specific

The early fullness was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.

event rates are more informative than hazard ratios alone

Mechanistically the bit that matters is method development. It explains most of the early profile and a decent chunk of the outcome.

event rates are more informative than hazard ratios alone

I am going to push back on this slightly.

You have restated the marketing copy. What is the actual substance here.

network selection matters, wrong chain is the expensive typo